Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 4051-4100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT07163806
Volumetric Parameter of 18F-FDG PET/CT in Characterizing Thyroid Incidentalomas
N/A
Not yet recruiting
88 participants
Started: Oct 30, 2025 · Completed: May 30, 2028
1 condition
1 sponsor
0 locations
NCT06730932
A Prospective,Single Arm, Multicenter Clinical Study of BTLA Monoclonal Antibody JS004 (B/T Lymphocyte Attenuator Factor Monoclonal Antibody) in Combination With Toripalimab in Patients With Unresectable or Advanced Renal Cell Carcinoma Who Had Failed Previous Immunotherapy
PHASE2
Not yet recruiting
31 participants
Started: Oct 30, 2025 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT07196384
Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CW
PHASE1
Not yet recruiting
15 participants
Started: Oct 30, 2025 · Completed: Dec 30, 2026
1 condition
2 sponsors
0 locations
NCT06825897
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
NA
Not yet recruiting
2,039 participants
Started: Oct 30, 2025 · Completed: Apr 30, 2028
1 condition
2 sponsors
1 location
NCT06447701
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
PHASE3
Not yet recruiting
486 participants
Started: Oct 30, 2025 · Completed: Jun 30, 2029
7 conditions
8 sponsors
0 locations
NCT07196163
An Exploratory Study of Golidocitinib in Adult Patients With ITP
PHASE1/PHASE2
Not yet recruiting
138 participants
Started: Oct 30, 2025 · Completed: Oct 30, 2029
1 condition
1 sponsor
1 location
NCT06840496
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
PHASE3
Recruiting
210 participants
Started: Oct 30, 2025 · Completed: Nov 30, 2026
1 condition
1 sponsor
24 locations
NCT07114562
Evaluation of the Safety and Performance of Epicare for the Treatment of Periorbital Wrinkles
NA
Not yet recruiting
50 participants
Started: Oct 30, 2025 · Completed: Nov 30, 2026
1 condition
1 sponsor
0 locations
NCT07181265
Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects
PHASE1
Not yet recruiting
48 participants
Started: Oct 30, 2025 · Completed: Jun 30, 2026
1 condition
1 sponsor
0 locations
NCT07203664
Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.
PHASE4
Not yet recruiting
30 participants
Started: Oct 30, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT07198789
Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia
NA
Not yet recruiting
40 participants
Started: Oct 30, 2025 · Completed: May 29, 2026
4 conditions
1 sponsor
0 locations
NCT07076849
Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females
PHASE2
Not yet recruiting
250 participants
Started: Oct 30, 2025 · Completed: Nov 30, 2030
2 conditions
1 sponsor
0 locations
NCT05173064
Effects of a Machine Learning-based Lower Limb Exercise Training System for Knee Pain
NA
Not yet recruiting
264 participants
Started: Oct 30, 2025 · Completed: Mar 31, 2027
2 conditions
1 sponsor
1 location
NCT06963554
Examining Whether Project Support Works
NA
Not yet recruiting
100 participants
Started: Oct 30, 2025 · Completed: Mar 31, 2028
3 conditions
2 sponsors
1 location
NCT07188805
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
PHASE3
Not yet recruiting
111 participants
Started: Oct 30, 2025 · Completed: Dec 30, 2029
2 conditions
1 sponsor
132 locations
NCT07195123
Evaluation of the SMART IBD App in Pediatric IBD
NA
Recruiting
70 participants
Started: Oct 30, 2025 · Completed: Aug 31, 2027
7 conditions
1 sponsor
1 location
NCT07216105
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
PHASE1
Recruiting
113 participants
Started: Oct 30, 2025 · Completed: Jan 31, 2030
6 conditions
1 sponsor
1 location
NCT06801223
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
PHASE1
Recruiting
48 participants
Started: Oct 30, 2025 · Completed: May 20, 2028
1 condition
2 sponsors
4 locations
NCT06930755
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
PHASE1
Recruiting
24 participants
Started: Oct 30, 2025 · Completed: Sep 26, 2027
1 condition
1 sponsor
1 location
NCT07193589
A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
PHASE2
Not yet recruiting
111 participants
Started: Oct 30, 2025 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT06138067
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
NA
Not yet recruiting
90 participants
Started: Oct 30, 2025 · Completed: Apr 30, 2026
2 conditions
2 sponsors
1 location
NCT06762717
FARAPULSE™ Pulsed Field Ablation System
N/A
Not yet recruiting
500 participants
Started: Oct 30, 2025 · Completed: Dec 31, 2029
1 condition
1 sponsor
0 locations
NCT07142551
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
PHASE2
Not yet recruiting
60 participants
Started: Oct 30, 2025 · Completed: Jun 1, 2034
1 condition
2 sponsors
1 location
NCT06836180
An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease
EARLY_PHASE1
Not yet recruiting
40 participants
Started: Oct 30, 2025 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT07172360
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
PHASE3
Not yet recruiting
420 participants
Started: Oct 30, 2025 · Completed: Aug 30, 2027
1 condition
1 sponsor
1 location
NCT07128290
PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma
PHASE2
Not yet recruiting
49 participants
Started: Oct 30, 2025 · Completed: Apr 30, 2029
1 condition
1 sponsor
9 locations
NCT07213817
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
PHASE1/PHASE2
Not yet recruiting
102 participants
Started: Oct 30, 2025 · Completed: Oct 30, 2028
2 conditions
1 sponsor
0 locations
NCT06783348
Radiopharmaceutical Treatment of Advanced Kidney Cancer
PHASE2
Not yet recruiting
48 participants
Started: Oct 30, 2025 · Completed: Jan 1, 2029
1 condition
2 sponsors
0 locations
NCT07174297
Acotiamide vs Itopride in Postprandial Distress Syndrome
PHASE3
Not yet recruiting
152 participants
Started: Oct 30, 2025 · Completed: Apr 30, 2027
1 condition
2 sponsors
0 locations
NCT07188740
Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia
PHASE1
Not yet recruiting
30 participants
Started: Oct 30, 2025 · Completed: Aug 30, 2029
1 condition
1 sponsor
0 locations
NCT06655766
Socket Preservation Using Socket-plug Technique With Alloplastic Putty Bone Versus Ice Cream Cone Technique in Extraction Socket With Buccal Dehiscence.
NA
Not yet recruiting
30 participants
Started: Oct 30, 2025 · Completed: Feb 1, 2026
1 condition
1 sponsor
0 locations
NCT07189338
Apneic Oxygenation With High-flow Nasal Oxygenation After Preoxygenation With Noninvasive Ventilation Before Intubation in Hypoxemic Patients in Intensive Care Unit.
NA
Not yet recruiting
500 participants
Started: Oct 30, 2025 · Completed: Nov 30, 2028
1 condition
1 sponsor
1 location
NCT07187336
A Pragmatic Randomized Controlled Trial: The Efficacy and Safety of Shoulder MSAT on in Patients With Shoulder Pain
NA
Not yet recruiting
98 participants
Started: Oct 30, 2025 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT06951269
Music Therapy During Hypothermia in the NICU
NA
Not yet recruiting
22 participants
Started: Oct 30, 2025 · Completed: Aug 1, 2027
6 conditions
1 sponsor
1 location
NCT07200479
A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms
PHASE1
Not yet recruiting
20 participants
Started: Oct 30, 2025 · Completed: Dec 30, 2027
1 condition
1 sponsor
3 locations
NCT07054242
A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC)
PHASE2
Not yet recruiting
52 participants
Started: Oct 30, 2025 · Completed: Jun 30, 2028
2 conditions
2 sponsors
1 location
NCT07202520
Evaluation of the Benefit of the H'Ability Home Device Used in Supervised Self-rehabilitation at Home on the Autonomy of Post-stroke Patients
NA
Not yet recruiting
44 participants
Started: Oct 30, 2025 · Completed: Sep 29, 2026
1 condition
2 sponsors
5 locations
NCT07201649
Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications
NA
Not yet recruiting
95 participants
Started: Oct 30, 2025 · Completed: Oct 30, 2029
1 condition
1 sponsor
1 location
NCT04480619
Safety and Efficacy of Ga68-IAC PET/CT for Diagnosis and Clinical Management in Metastatic Breast Cancer Patients
PHASE1/PHASE2
Not yet recruiting
25 participants
Started: Oct 30, 2025 · Completed: Aug 30, 2027
1 condition
5 sponsors
3 locations
NCT07155317
Time-of-Day Specified Ipilimumab and Nivolumab for the Treatment of Stage IV Unresectable Melanoma, The TIME Trial
PHASE2
Not yet recruiting
99 participants
Started: Oct 29, 2025 · Completed: Dec 31, 2027
10 conditions
2 sponsors
2 locations
NCT07110662
New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.
PHASE1/PHASE2
Not yet recruiting
9 participants
Started: Oct 29, 2025 · Completed: Apr 29, 2029
3 conditions
3 sponsors
1 location
NCT07160725
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
PHASE1/PHASE2
Not yet recruiting
315 participants
Started: Oct 28, 2025 · Completed: Aug 1, 2028
1 condition
1 sponsor
18 locations
NCT06041503
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
PHASE2
Not yet recruiting
68 participants
Started: Oct 28, 2025 · Completed: Oct 1, 2028
3 conditions
1 sponsor
1 location
NCT06676059
SMART-r: Substance Monitoring and Active Relapse Tracking Repository
N/A
Recruiting
10,000 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2044
2 conditions
1 sponsor
1 location
NCT06744283
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
N/A
Recruiting
20 participants
Started: Oct 28, 2025 · Completed: Jan 30, 2026
1 condition
1 sponsor
1 location
NCT03895645
Connors Protocol for the Management and Use of Stored Human Specimens (Stored Human Specimens)
N/A
Enrolling by invitation
1,000 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT06694454
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2
Not yet recruiting
60 participants
Started: Oct 28, 2025 · Completed: Dec 31, 2034
5 conditions
1 sponsor
1 location
NCT06406465
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
PHASE2
Recruiting
60 participants
Started: Oct 28, 2025 · Completed: Jul 30, 2028
5 conditions
1 sponsor
1 location
NCT06615973
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
N/A
Recruiting
450 participants
Started: Oct 28, 2025 · Completed: Feb 1, 2026
4 conditions
1 sponsor
1 location
NCT05473429
Characterization of Nociception Phenotype in Individuals With Intellectual Disability
NA
Recruiting
215 participants
Started: Oct 28, 2025 · Completed: Oct 6, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
79
80
81
82
83
84
85
More pages
2369
Next